MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RAESS, B. U.
Right arrow Articles by VINCENZI, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RAESS, B. U.
Right arrow Articles by VINCENZI, F. F.

Molecular Pharmacology, Vol 18, 253-258, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics

Calmodulin Activation of Red Blood Cell (Ca2+ + Mg2+)-ATPase and Its Antagonism by Phenothiazines

BEAT U. RAESS 1 and FRANK F. VINCENZI 1

1 Department of Pharmacology, School of Medicine, University of Washington, Seattle, Washington 98195

Plasma membranes prepared from human red blood cells exhibit a Ca2+-activated, Mg2+-dependent adenosine triphosphatase activity which is a biochemical expression of the Ca2+ pump. The activity of this (Ca2++Mg2+-ATPase was increased severalfold by the Ca2+-binding protein, calmodulin, whether purified or present in a crude red blood cell hemolysate. The phenothiazines chlorpromazine (CPZ) and trifluoperazine (TFP) antagonized calmodulin activation of (Ca2++Mg2+-ATPase in an apparently competitive manner. CPZ and TFP were less effective in antagonizing (Ca2++Mg2+)-ATPase activity in the absence of added calmodulin. TFP antagonized the calmodulin-dependent portion of (Ca2++Mg2+)-ATPase activity relatively specifically at 10 and 30 µM. Up to 100 µM neither haloperidol nor d - or l-butaclamol significantly antagonized calmodulin-induced activation of the (Ca2++Mg2+-ATPase. Basal ATPase activity was also not inhibited. In contrast to the lack of inhibition by nonphenothiazine neuroleptics, ruthenium red nonspecifically antagonized both basal and calmodulin-activated (Ca2++Mg2+)-ATPase activity. It was concluded that phenothiazines antagonize activation of the (Ca2++Mg2+)-ATPase by binding to calmodulin. Ruthenium red appears to have a different mechanism of action. Because the potent neuroleptic nonphenothiazines, haloperidol and butaclamol, fail to antagonize calmodulin activation of red blood cell (Ca2++Mg2+-ATPase it appears that general anti-calmodulin activity does not correlate with neuroleptic activity.

Note:
ACKNOWLEDGMENTS We would like to thank Dr. T. R. Hinds for his help in the preparation and purification of calmodulin. Dr. H. Green at Smith, Kline and French Laboratories kindly provided a generous gift of [3H]trifluoperazine.

Submitted on February 4, 1980
Accepted on March 24, 1980







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics